无抽搐电休克特殊人群的治疗(2)
6结语
MECT对治疗重性精神病和严重抑郁症病人,有效安全、可靠、及时减少病情迁延,但对特殊人群治疗需要考虑病情变化和特点。对患者的风险进行分析评估,有真对性术前准备作MECT时,掌握患者病情,应谨慎小心,予必要的医疗和麻醉处理,尤其是长期治疗不愈或药物抵抗的患者群体,更加不可缺少的治疗手段,前提一定要取得知情同意。但事实证明MECT是具有挽救生命的治疗措施,不宜延误。MECT也有它的局限性,虽然目前做MECT无抽搐,但有加速基础代谢率,对合并躯体重病人还是要考虑风险性,对儿童青少年的目前研究资料很少有待于考证。对无行为能力的患者,又无人管的五类患者有待立法解决。
参考文献
[1]Rabheru K.The use of electroconvulsive therapy in spevial patient populations[J].Can.J.Psychiatry,2001,46:710～719.
[2]Rey JM,Walter Ghalf.A century of Eet use in young people AMJ[J]. Psychiatry,1997,154:595～602.
[3]Walker R,Swartg CM.Electrocon vulsive therapy during high-risk pregnaney[J].Gen Hosp peychiatry,1994,16:348～353.
[4]American psychiatric Association praetice for the treatment of patients with bipolar AMJ[J].Psychiatry,1994,151(12suppl):1～36.
[5]Guay J,Grenier Y,Varin F.Clinical pharmacokinetics of neuromuscular relaxauts[J].Preg Nancy Clin Pharmaeokiaet,1998,34:483～496.
[6]Folk JF,Kellner CH,Bedle MD,et al. Anesthesia for electroconvulsive[J].Therapy:a review J Ect,2000,16:157～170.
【收稿日期】 2010-09-13, 百拇医药(于志淼 李梅)
MECT对治疗重性精神病和严重抑郁症病人,有效安全、可靠、及时减少病情迁延,但对特殊人群治疗需要考虑病情变化和特点。对患者的风险进行分析评估,有真对性术前准备作MECT时,掌握患者病情,应谨慎小心,予必要的医疗和麻醉处理,尤其是长期治疗不愈或药物抵抗的患者群体,更加不可缺少的治疗手段,前提一定要取得知情同意。但事实证明MECT是具有挽救生命的治疗措施,不宜延误。MECT也有它的局限性,虽然目前做MECT无抽搐,但有加速基础代谢率,对合并躯体重病人还是要考虑风险性,对儿童青少年的目前研究资料很少有待于考证。对无行为能力的患者,又无人管的五类患者有待立法解决。
参考文献
[1]Rabheru K.The use of electroconvulsive therapy in spevial patient populations[J].Can.J.Psychiatry,2001,46:710～719.
[2]Rey JM,Walter Ghalf.A century of Eet use in young people AMJ[J]. Psychiatry,1997,154:595～602.
[3]Walker R,Swartg CM.Electrocon vulsive therapy during high-risk pregnaney[J].Gen Hosp peychiatry,1994,16:348～353.
[4]American psychiatric Association praetice for the treatment of patients with bipolar AMJ[J].Psychiatry,1994,151(12suppl):1～36.
[5]Guay J,Grenier Y,Varin F.Clinical pharmacokinetics of neuromuscular relaxauts[J].Preg Nancy Clin Pharmaeokiaet,1998,34:483～496.
[6]Folk JF,Kellner CH,Bedle MD,et al. Anesthesia for electroconvulsive[J].Therapy:a review J Ect,2000,16:157～170.
【收稿日期】 2010-09-13, 百拇医药(于志淼 李梅)